Fujishiro Mitsuhiro
World J Gastroenterol. 2006 Aug 28;12(32):5108-12. doi: 10.3748/wjg.v12.i32.5108.
Recent advances in techniques of therapeutic endoscopy for stomach neoplasms are rapidly achieved. One of the major topics in this field is endoscopic submucosal dissection (ESD). ESD is a new endoscopic technique using cutting devices to remove the tumor by the following three steps: injecting fluid into the submucosa to elevate the tumor from the muscle layer, pre-cutting the surrounding mucosa of the tumor, and dissecting the connective tissue of the submucosa beneath the tumor. So the tumors are resectable in an en bloc fashion, regardless of the size, shape, coexisting ulcer, and location. Indication for ESD is strictly confined by two aspects: the possibility of nodal metastases and technical difficulty, which depends on the operators. Although long-term outcome data are still lacking, short-term outcomes of ESD are extremely favourable and laparotomy with gastrectomy is replaced with ESD in some parts of therapeutic strategy for early gastric cancer.
胃肿瘤治疗性内镜技术最近取得了迅速进展。该领域的主要课题之一是内镜黏膜下剥离术(ESD)。ESD是一种新的内镜技术,使用切割设备通过以下三个步骤切除肿瘤:向黏膜下层注射液体以使肿瘤从肌层抬起,预先切割肿瘤周围的黏膜,以及剥离肿瘤下方黏膜下层的结缔组织。因此,无论肿瘤的大小、形状、是否并存溃疡以及位置如何,都可以整块切除肿瘤。ESD的适应证严格受两个方面限制:淋巴结转移的可能性和技术难度,而技术难度取决于操作者。尽管仍缺乏长期结果数据,但ESD的短期结果非常良好,在早期胃癌治疗策略的某些部分,ESD已取代了剖腹胃切除术。